Results 221 to 230 of about 190,499,234 (278)

A Decade Later: Trends in Fellowship Training and Secondary Board Certification Among Emergency Medicine Residency Leaders. [PDF]

West J Emerg Med
Langan D, Shogan L, Hassan SE, Caputo W, Husain A, Chacko J, Mohamadi A, Greenstein J, Hahn B.   +8 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Board of Directors

Journal of Thoracic Oncology, 2019
openaire   +1 more source

Multiorganizational Recommendations for Point-of-Care Ultrasound in Family Medicine Residency Education. [PDF]

Fam Med
Paulus R.
europepmc   +1 more source

On the Birth of US Family Medicine and the Residency Assistance Program. [PDF]

Fam Med
Gilchrist VJ, Graham R, Kahn NB, Ostergaard DJ, Heide K.   +4 more
europepmc   +1 more source

Simultaneous onset of familial hemophagocytic lymphohistiocytosis and T-cell large granular lymphocytic leukemia in an adult. [PDF]

Ann Hematol
Dierks F, Paulsen FO, Lehmberg K, Rosenwald A, Bokemeyer C, Weisel K, Seidel C.   +6 more
europepmc   +1 more source

Trainee and Faculty Perspectives of Neurointerventional Curricula in Residency: a Scoping Review. [PDF]

Clin Teach
Yabut JM, Al Bader R, Affana C, Chainey J, Kumar A.   +4 more
europepmc   +1 more source

Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial. [PDF]

Blood Neoplasia
Sekeres MA, Santini V, Zeidan AM, Platzbecker U, Komrokji RS, Díez-Campelo M, Fenaux P, Savona MR, Madanat YF, Valcárcel D, Regnault A, Mazerolle F, Sun L, Wan Y, Berry T, Feller F, Navada S, Oliva EN.   +17 more
europepmc   +1 more source

Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia.

Blood
Wang ES, Erba H, Zeidan AM, Roboz GJ, Altman JK, Advani AS, Lin TL, Strickland SA, Juckett MB, Pratz KW, Mangan JK, McMahon CM, Alsfeld LC, Balasubramanian SK, Guru Murthy GS, Rotta M, Palmisiano ND, McCloskey J, Saliba AN, Khawandanah M, Madanat YF, Naqvi K, Qasrawi AH, Schiller GJ, Badar T, Gojo I, Yaghmour G, Osman D, Zhang H, Tian Y, Soifer HS, Riches M, Corum D, Leoni M, Fathi AT, Issa GC.   +35 more
europepmc   +1 more source